TABLE 1.
Changes in laboratory findings of both cases
| Case 1 | Case 2 | ||||||
|---|---|---|---|---|---|---|---|
| On admission | D 7 | D 18 | D 29 | On admission | D 7 | D 17 | |
| Complete blood cells | |||||||
| White blood cell,/µL | 6630 | 13 910 | 13 840 | 4980 | 3950 | 4680 | 5850 |
| Hemoglobin, g/dL | 14.5 | 12.5 | 11.9 | 10.6 | 14.1 | 15.0 | 13.1 |
| Platelet, 103/µL | 313 | 371 | 323 | 324 | 111 | 129 | 207 |
| Neutrophil, /µL (%) | 5417 (81.7) | 12 157 (87.4) | 10 740 (77.6) | 1668 (33.5) | 2090 (52.9) | 2434 (52.0) | 2469 (42.2) |
| Lymphocyte, /µL (%) | 643 (9.7) | 654 (4.7) | 1882 (13.6) | 2092 (42.0) | 1339 (33.9) | 1470 (31.4) | 2469 (42.2) |
| Monocyte, /µL (%) | 557 (8.4) | 1085 (7.8) | 1024 (7.4) | 891 (17.9) | 521 (13.2) | 679 (14.5) | 801 (13.7) |
| Sodium, mEq/L | 130 | 134 | 143 | 143 | 133 | 133 | 137 |
| Potassium, mEq/L | 5.0 | 4.3 | 4.3 | 4.9 | 4.9 | 5.2 | 4.4 |
| BUN, mg/dL | 26 | 23 | 33 | 21 | 33 | 47 | 34 |
| Creatinine, mg/dL | 2.02 | 1.59 | 1.39 | 1.39 | 1.85 | 2.27 | 1.74 |
| eGFR, mL/min/1.73 m2 | 41.2 | 55.0 | 64.7 | 64.7 | 39.8 | 31.1 | 42.9 |
| Albumin, g/dL | 4.2 | 3.3 | 3.4 | 3.8 | 3.7 | 3.7 | 3.7 |
| AST, U/L | 32 | 12 | 16 | 20 | 14 | 16 | 15 |
| ALT, U/L | 35 | 21 | 30 | 45 | 10 | 9 | 11 |
| CRP, mg/dL | 4.6 | 3.4 | 0.6 | 0.1 | 2.7 | 2.5 | 0.1 |
| Urine albumin | 2+ | 1+ | Negative | Trace | 2+ | 1+ | Trace |
| uPCR, g/g Cr | 1.25 | 0.87 | 0.21 | 0.09 | ND | 0.75 | 0.58 |
| COVID-19 | |||||||
| Nasopharyngeal swab | Positive | Positive | Positive | Negative | Positive | Positive | Negative |
| Sputum | Positive | Positive | Positive | Negative | Positive | Positive | Negative |
Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase; BUN, blood urea nitrogen; COVID-19, coronavirus disease 2019; CRP, C-reactive protein; D, admission date; eGFR, estimated glomerular filtration rate; ND, not done; uPCR, urine protein to creatinine ratio.